Evaluation of HIV Reporting Form in Sana'a City, Yemen, 2016.
HIV
Yemen
evaluation
field epidemiology training program
reporting form
Journal
Inquiry : a journal of medical care organization, provision and financing
ISSN: 1945-7243
Titre abrégé: Inquiry
Pays: United States
ID NLM: 0171671
Informations de publication
Date de publication:
Historique:
entrez:
9
5
2019
pubmed:
9
5
2019
medline:
18
12
2019
Statut:
ppublish
Résumé
Yemen has witnessed a significant rise in AIDS-related deaths because of very poor access to antiretroviral treatment and because of the current war situation. This study aimed to assess the attributes of human immunodeficiency virus (HIV) reporting form, including usefulness, simplicity, flexibility, and acceptability, which is used for reporting HIV cases in Sana'a, Yemen. A descriptive cross-sectional study was conducted among 311 physicians from public and private health facilities in Sana'a city. Physicians were interviewed using a structured questionnaire to assess the form's attributes. The mean score was calculated for each attribute and converted to percentages which were interpreted as very poor, poor, average, good, and excellent. The usefulness overall score was 76%, indicating average usefulness. Of the total participants, 283 (91%) and 304 (97.7%) stated that the form is clear and easy to fill, respectively. More than two-thirds (68.5%) of physicians stated that the form ensures the privacy of the customer's identity. The simplicity attribute score was 74.5%, indicating average simplicity. The overall flexibility was 69.2%, indicating average flexibility. A total of 175 (56%) physicians indicated that they are completely satisfied with the reporting form. The acceptability score was 75.2%, indicating that the HIV/AIDS reporting form of HIV is average in acceptability. The HIV/AIDS reporting form in Yemen was scored average in usefulness, simplicity, flexibility, and acceptability. Training health workers on using the reporting form would improve the performance of HIV/AIDS reporting. Moreover, the reporting form could be adapted to be integrated with other surveillance such as tuberculosis surveillance.
Identifiants
pubmed: 31064261
doi: 10.1177/0046958019847020
pmc: PMC6506924
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
46958019847020Références
Lancet HIV. 2016 Aug;3(8):e361-e387
pubmed: 27470028
Lancet. 2014 Sep 13;384(9947):1005-70
pubmed: 25059949
Lancet Infect Dis. 2016 Dec;16(12):1385-1398
pubmed: 27665254
MMWR Recomm Rep. 2001 Jul 27;50(RR-13):1-35; quiz CE1-7
pubmed: 18634202
J Acquir Immune Defic Syndr. 2009 Jul 1;51 Suppl 3:S83-95
pubmed: 19553783